Adagio Medical Announces the Closing of the Business Combination with ARYA IV, Creating a Publicly Traded Company Focused on the Innovative Technologies for Treatment of Cardiac Arrhythmias Jul 31, 2024 04:01PM
Nautilus Biotechnology Debuts as Publicly Traded Company, Seeks to Deliver on the Untapped Potential of the Human Proteome Jun 9, 2021 10:05PM
Form SC 13G ARYA Sciences Acquisitio Filed by: RA CAPITAL MANAGEMENT, L.P. Feb 16, 2021 04:48PM
Next-Gen Proteomics Company Nautilus Biotechnology to List on Nasdaq Through Merger with Arya Sciences Acquisition Corp III Feb 8, 2021 07:00AM